Literature DB >> 29988900

Effects of particulate matter on allergic respiratory diseases.

Jin-Zhun Wu1, Dan-Dan Ge2,3, Lin-Fu Zhou4, Ling-Yun Hou3, Ying Zhou3,5, Qi-Yuan Li2,3,5.   

Abstract

The health impact of airborne particulate matter (PM) has long been a concern to clinicians, biologists, and the general public. With many epidemiological studies confirming the association of PM with allergic respiratory diseases, an increasing number of follow-up empirical studies are being conducted to investigate the mechanisms underlying the toxic effects of PM on asthma and allergic rhinitis. In this review, we have briefly introduced the characteristics of PM and discussed its effects on public health. Subsequently, we have focused on recent studies to elucidate the association between PM and the allergic symptoms of human respiratory diseases. Specifically, we have discussed the mechanism of action of PM in allergic respiratory diseases according to different subtypes: coarse PM (PM2.5-10), fine PM (PM2.5), and ultrafine PM.

Entities:  

Keywords:  Allergic respiratory diseases; Coarse PM; Fine PM; Particulate matter; Ultrafine PM

Year:  2018        PMID: 29988900      PMCID: PMC6034084          DOI: 10.1016/j.cdtm.2018.04.001

Source DB:  PubMed          Journal:  Chronic Dis Transl Med        ISSN: 2095-882X


Physical and chemical characteristics of particulate matter

The growing population density and the rapid urbanization lead to the deterioration of air quality worldwide, especially in China. Atmospheric particulate matter (PM; pl. “particulates”), consisting of both primary and secondary particles, is one of the major air pollutants. Primary PM is generated from road transport, combustion (mainly coal burning), and other industrial processes, whereas secondary PM is generated through chemical reactions among different primary particulates in the atmosphere (e.g., sulfates and nitrates, formed from the conversion of SO2 and NO2 into their respective acids). Particulates are classified into three categories according to their aerodynamic diameters: coarse PM (PM2.5-10, aerodynamic diameter ranging from 2.5 to 10 μm), which deposits primarily in the primary bronchi; fine PM (PM2.5, ranging from 0.1 to 2.5 μm), which can penetrate the alveoli and terminal bronchioles; and ultrafine PM (PM0.1 or UFP, less than 0.1 μm), which can cross cell membranes and interact directly with cellular structures.3, 4 PM toxicity arises from two aspects. First, the particulates can penetrate the gas-exchange region of the lung and thereby infiltrate the circulatory system through layers of alveolar obstruction.5, 6 Second, particulates can absorb many other airborne toxic substances on their surface area, such as heavy metals, polycyclic aromatic hydrocarbons, and organic and inorganic ions.

PM as a risk factor to public health

PM has become a public health concern, having being implicated as the cause of 4.24 million deaths in 2015, 7.8% higher than that in 2005. In 2015, PM ranked 6th on the list of 10 most hazardous factors contributing to global disability-adjusted life-years. Many epidemiological studies worldwide have addressed the correlation between the concentrations of PM and hospital visits due to respiratory diseases (Table 1).9, 10, 11, 12, 13, 14, 15, 16
Table 1

Representative epidemiological studies of the association between particulate matter concentrations and hospital visits due to respiratory diseases.

ReferencesStudyLocationTimePMAnalysismethodsPopulationDiseasesFindingsRR/OR/IR (95% CI)
9Impact of PM on human health within the urban environmentAthens, Greece2001–2013PM10AirQ2.2.3 modelAll agesHARDA strong relationship between the HARD cases and PM10 exposure levels
10Effects of PM on respiratory diseaseBusan, Korea2007–2010PM2.5Multivariate analysisAll agesHARDA significant increase in HARD with increasing PM levelsRR: 1.008 (1.007–1.009)
PM10RR: 1.003 (1.003–1.004)
11Associations between air pollutants and pediatric asthma hospital admissionsNew York, USA1999–2009PM2.5Generalized additive models6–18 yearsAsthma HAsPM2.5was statistically significantly associated with increased asthma HAsRR: 1.02 (1.00–1.04)
12Correlation between air pollution and children's asthma-related emergency hospital visitsSoutheastern France2013PM10Nested case–control study3–18 yearsChildren's asthma ERVsPM10 near children's homes increased the risk of asthma ERVsOR: 1.02 (1.01–1.04)
13Correlation between PM10/PM2.5 and outpatient visits for respiratory diseaseJinan, China2013–2015PM2.5Generalized additive modelAll agesRespiratory diseasesAmbient PM10 and PM2.5 pollution was positively associated with daily hospital visits due to respiratory diseaseIR: 0.36% (0.30%–0.43%)
PM10IR: 0.50% (0.30%–0.70%)
14Effects of fine PM on emergency room visits for asthmaSouthern Taiwan, China2008–2010PM2.5Quasi-Poisson generalized additive modelChildrenHospital ERVs for asthmaChildren were susceptible to the effects of PM2.5RR: 1.016 (1.002–1.030)
15Effects of exposure to indoor PM on symptoms and acute exacerbations in COPD patientsSouthwestern Taiwan, China2014–2016PM10Generalized estimating equation analysisAll agesAdmission due to acute exacerbation of COPDPM was associated with worse respiratory symptoms and increased risk of COPD exacerbation in patients with moderate to very severe COPDOR: 16.2 (3.10–84.9)
16Correlation between fine particulate air pollution and hospital visits for asthmaBeijing, China2010–2012PM2.5Generalized additive Poisson modelAll agesAsthma HVsShort-term elevations may increase the risk of asthma exacerbationIR: 0.67% (0.53%–0.81%)
Asthma OVsIR: 0.65% (0.51%–0.80%)
Asthma ERVsIR: 0.49% (0.35%–0.64%)

PM: particulate matter; RR: relative risk (the relative risk of increased hospital visits with a 10 μg/m3 increment of PM); OR: odds ratio; IR: increase ratio (the increase ratio of hospital visits with a 10 μg/m3 increment of PM2.5); CI: confidence interval; HARD: hospital admissions for respiratory diseases; HAs: hospital admissions; ERVs: emergency room visits; COPD: chronic obstructive pulmonary disease; HVs: Hospital visits; OVs: Outpatient visits; –: not applicable.

Representative epidemiological studies of the association between particulate matter concentrations and hospital visits due to respiratory diseases. PM: particulate matter; RR: relative risk (the relative risk of increased hospital visits with a 10 μg/m3 increment of PM); OR: odds ratio; IR: increase ratio (the increase ratio of hospital visits with a 10 μg/m3 increment of PM2.5); CI: confidence interval; HARD: hospital admissions for respiratory diseases; HAs: hospital admissions; ERVs: emergency room visits; COPD: chronic obstructive pulmonary disease; HVs: Hospital visits; OVs: Outpatient visits; –: not applicable. PM interacts directly with the human body. Although particulates can be detected in many organs such as the lungs, liver, kidneys, heart, and brain, their deposition patterns show that lungs are the primary site. Because of the heterogeneity in their chemical and physical properties, there is no standard toxic dose for PM. According to Fann et al,even exposure to PM at a concentration below the US national standards poses a significant risk to health. Because of its substantial health impacts, the World Health Organization Air Quality Guidelines (WHOAQG) have established PM2.5 as the indicator of pollution caused by particulates in 2006.

Effects of PM on allergic respiratory diseases

Asthma and allergic rhinitis (AR) are the major types of allergic respiratory diseases, characterized by their similar pathophysiological changes and inflammatory responses. The major risk factors of allergic respiratory diseases are genetic (germline risk loci) and environmental factors (including PM). Although many studies have confirmed that exposure to particulates has significant effects on asthma and AR, the mechanism by which PM influences these diseases is not fully understood. In the following sections, the latest advances that have helped in elucidating the pathogenicity of different PM subtypes are summarized (Fig. 1).
Fig. 1

Different pathways of PM toxicity and their mechanisms in allergic respiratory diseases. (A) PM2.5-10 activates neutrophils and eosinophils; (B) PM2.5 induces antigen-presenting cell-mediated inflammatory responses; (C) PM2.5 induces oxidative stress; (D) PM2.5 leads to apoptosis and autophagy; and (E) PM2.5 causes imbalance of T helper cells. PM: particulate matter; NE: neutrophils; EOS: eosinophils; IL: interleukin; H1R: H1 receptor; GM-CSF: granulocyte-macrophage colony stimulating factor; TNF: tumor necrosis factor; COX-2: cyclooxygenase-2; PI3K: phosphatidylinositol-4,5-bisphosphate 3-kinase; PIP2: phosphatidylinositol (4,5)-bisphosphate; PIP3: phosphatidylinositol (3,4,5)-trisphosphate; PTEN: phosphatase and tensin homolog; NrF2: nuclear factor (erythroid-derived 2)-like 2; PDK1: phosphoinositide-dependent kinase-1; Akt: protein kinase B; PKB: protein kinase B; GCLC: glutamate-cysteine ligase catalytic subunit; HO-1: heme oxygenase-1; NQO-1: NADPH quinone oxidoreductase; GSK-3β: glycogen synthase kinase-3 beta; Caspase: cysteine aspartic acid protease; Rac1: ras-related C3 botulinum toxin substrate 1; p70s6k: p70 ribosomal protein S6 kinase; mdm2: Mouse double minute 2 homolog; APC: antigen-presenting cell; CD: cluster of differentiation; CR3: complement receptor 3; LC3A/B: light chain 3A/B; IFN-γ: interferon-gamma; ST2: IL-33 receptor; Th: T-helper; UFP: ultrafine particulate matter.

Different pathways of PM toxicity and their mechanisms in allergic respiratory diseases. (A) PM2.5-10 activates neutrophils and eosinophils; (B) PM2.5 induces antigen-presenting cell-mediated inflammatory responses; (C) PM2.5 induces oxidative stress; (D) PM2.5 leads to apoptosis and autophagy; and (E) PM2.5 causes imbalance of T helper cells. PM: particulate matter; NE: neutrophils; EOS: eosinophils; IL: interleukin; H1R: H1 receptor; GM-CSF: granulocyte-macrophage colony stimulating factor; TNF: tumor necrosis factor; COX-2: cyclooxygenase-2; PI3K: phosphatidylinositol-4,5-bisphosphate 3-kinase; PIP2: phosphatidylinositol (4,5)-bisphosphate; PIP3: phosphatidylinositol (3,4,5)-trisphosphate; PTEN: phosphatase and tensin homolog; NrF2: nuclear factor (erythroid-derived 2)-like 2; PDK1: phosphoinositide-dependent kinase-1; Akt: protein kinase B; PKB: protein kinase B; GCLC: glutamate-cysteine ligase catalytic subunit; HO-1: heme oxygenase-1; NQO-1: NADPH quinone oxidoreductase; GSK-3β: glycogen synthase kinase-3 beta; Caspase: cysteine aspartic acid protease; Rac1: ras-related C3 botulinum toxin substrate 1; p70s6k: p70 ribosomal protein S6 kinase; mdm2: Mouse double minute 2 homolog; APC: antigen-presenting cell; CD: cluster of differentiation; CR3: complement receptor 3; LC3A/B: light chain 3A/B; IFN-γ: interferon-gamma; ST2: IL-33 receptor; Th: T-helper; UFP: ultrafine particulate matter.

Coarse PM (PM2.5-10)

Coarse PM is deposited in extra thoracic airways and induces various symptoms of pulmonary inflammation. Studies have shown the pulmonary toxicity of coarse PM both in vivo and in vitro.21, 22, 23 We discuss three detailed mechanisms of such toxicity induced by coarse PM (Fig. 1A,B, and E) below.

PM2.5-10 activates neutrophils and eosinophils

Diesel exhaust particles (DEPs), a type of coarse PM, exacerbate the symptoms of AR by increasing the levels of the proinflammatory cytokines interleukin (IL)-8, IL-1β, granulocyte-macrophage colony stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-α) in nasal epithelial cells.24, 25 Terada et al claimed that DEPs activate proinflammatory cytokines by upregulating histamine H1 receptor (H1R) expression. The proinflammatory cytokines further induce neutrophils and eosinophils, leading to inflammatory responses. In addition, PM2.5-10 was shown to increase the number of IL-5-induced eosinophils in exposed allergic mice.

PM2.5-10 induces antigen-presenting cell-mediated inflammatory responses

Becker et al demonstrated that PM2.5-10 modulates airway macrophage host defenses by significantly increasing IL-6 levels and suppressing cluster of differentiation (CD) 11b+ macrophages in human alveoli. In asthmatic patients exposed to PM2.5-10, an inflammatory response was observed with decreased expression of the innate immune receptors CD11b/complement receptor 3 (CR3) and CD64/FcγRI, and the antigen-presenting receptors CD40 and CD86/B7-2, and concomitantly increased expression of the inflammatory receptor CD16/FcγRIII and the low-affinity IgE receptor CD23 in macrophages. DEPs induced murine dendritic cell activity, causing their migration to the mediastinal lymph node, which strengthened the immune response via the nuclear factor-erythroid 2-related factor 2 (Nrf2) signaling pathway.

PM2.5-10 induces T-helper (Th)2- and Th17-mediated immune responses

DEP was shown to induce a Th2-mediated immune response by suppressing the expression of IL-12 and interferon-gamma (IFN-γ), and increasing IL-10 secretion in antigen-specific T cells. Similarly, Chan et al reported that DEPs provoke a Th2-mediated immune response in asthmatic mice by increasing IL-10 secretion in lipopolysaccharide-induced antigen-specific T cells through the Nrf2 signaling pathway. Co-exposure to DEPs and home dust mites induced allergen-specific Th2 and Th17 cells via the IL-33/ST2 (IL-33 receptor) pathway in the lungs of PM-exposed asthmatic mice.30, 31 The same responses could be triggered by co-exposure of DEP with a low level of soybean allergen. Inflammatory responses cause a series of pathological changes in allergic respiratory diseases. Kobayashi et al determined that DEPs cause a severe nasal allergic reaction in AR mice. Guinea pigs exposed to DEPs displayed symptoms of nasal mucosal hyperresponsiveness.34, 35 The aforementioned immune activities of PM2.5-10 arise from the enriched heavy metal constituents, more biogenic materials with higher endotoxin contents, and other toxic absorbents, which lead to a stronger short-term effect on respiratory diseases compared with other PM subtypes.36, 37, 38, 39

Fine PM (PM2.5)

Unlike PM2.5-10, PM2.5 is not only deposited in extra thoracic airways but also penetrates deeper and farther into the alveoli through air flow and diffusion. Hence, PM2.5 can induce various symptoms of pulmonary inflammation and structure impairment (Fig. 1C–E).

PM2.5 causes imbalance of T helper cells

High concentrations of PM2.5 upregulate TNF-α and the Th2-mediated cytokines IL-4 and IL-10, while downregulating the Th1-mediated cytokine IFN-γ, which leads to an imbalance of the Th1/Th2 ratio.41, 42 PM2.5 was shown to significantly increase the expression of IL-13 and IL-17. In a study on rats with AR, the authors pointed out that the expression of IFN-γ, IL-4, IL-5, IL-33, intercellular adhesion molecule 1 (Icam1), and vascular cell adhesion molecule 1 (Vcam1) was increased in a PM2.5 concentration-dependent manner. High expression levels of INF-γ, IL-4, and IL-13 were also seen in the nasal lavage fluid. The Th1/Th2 imbalance was mainly driven by the activation of GATA binding protein 3 (Gata3) and the suppression of T-box 21 (T-bet) in AR rats.44, 45, 46, 47, 48, 49 Liu et al showed that PM2.5 exacerbates asthma by activating the expression of transient receptor potential cation channel, subfamily A, member 1 (Trpa1) and transient receptor potential cation channel, subfamily V, member 1 (Trpv1) protein in the epithelial cells of asthmatic mice. Thus, high concentrations of PM2.5 promote Th2-and Th17-mediated immune responses in AR and asthmatic mice.41, 42, 51, 52, 53 Following exposure to PM2.5, the lungs exhibit a series of pathological changes, such as inflammatory cell infiltration, bronchial smooth muscle thickening, and bronchial mucosal injury in asthmatic mice. PM2.5 treatment of rats with ovalbumin (OVA)-induced AR resulted in increased sneezing and nose scratching events, with goblet cell hyperplasia and collagen deposition in the pathological state.

PM2.5 induces oxidative stress in asthma

Exposure to PM2.5 is associated with oxidative stress and impaired lung function.54, 55, 56 A burst of reactive oxygen species induced by PM2.5 was found in the neutrophils of asthmatic patients. Deng et al reported that PM2.5 induces oxidative stress by increasing the expression of glutamate-cysteine ligase catalytic subunit (GCLC), heme oxygenase-1 (HO-1), and NADPH quinone oxidoreductase (NQO-1)in human lung epithelial cells (A549), and thereby activates Nrf2 in the phosphatidylinositol-4,5-bisphosphate 3-kinase (PIK3)/AKT signaling pathway. Huang et al reported that water-soluble PM2.5 (WSPE) induced an oxidative stress response in A549 cells. Becker et al revealed that PM2.5 induces oxidative stress responses by inducing TNF-α, IL-6, and cyclooxygenase-2 (COX-2) expression in alveolar macrophages and human bronchial epithelial cells.

PM2.5 leads to apoptosis and autophagy in asthma

Exposure to PM2.5 can also induce apoptosis and autophagy. WSPE induced apoptosis in lung epithelial cells through the p53, c-Myc, and p21 signaling pathways. The particulates also caused cell autophagy through upregulation of LC3A/B (biomarkers of autophagy) in asthmatic mice. Deng et al reported that PM2.5 induces apoptosis and autophagy via three pathways in human lung epithelial cells: the TNF-α signaling pathway; the intrinsic apoptosis pathway via caspase-8 and caspase-3 signaling; and the cell autophagy pathway via caspase-9,caspase-3,and B-cell lymphoma 2 (BCL2).

UFP

With an even smaller size, UFP can cross cell membranes and directly interact with cellular structures,3, 4potentially posing a high risk of respiratory disease development (Fig. 1E).

UFP causes severe inflammation in asthma

UFP can escape mucociliary clearance and ingestion by alveolar macrophage scavenging. One study detected UFP in the blood immediately after inhalation, and the particulates remained in the lungs for up to 6h after installation. Therefore, UFP can induce severe eosinophilic inflammatory responses, alveolar macrophage chemotaxis, and more epithelial damage in vivo.64, 65

UFP induces Th2-mediated inflammation

In OVA-sensitized mice, UFP promoted the proliferation of peribronchial lymph node cells and caused a Th2-mediated immune response66, 67 by activating the cytokines IL-4, IL-5, IL-10, and IL-13. IL-5 and IL-6 were also shown to be significantly increased in the bronchoalveolar lavage fluid of UFP-exposed mice.4, 27, 68 In another study, a high dose of ultrafine carbon black particles or ultrafine TiO2 particles, co-exposed with OVA, led to a high level of OVA-specific IgE in asthmatic mice. Ultrafine CeO2 particles (produced by motor vehicle combustion) significantly increased the levels of TNF-α and IL-1β as well as neutrophils in exposed mice.

Summary and perspectives

In summary, PM triggers a series of biological processes including innate immunity inflammation, oxidative stress, apoptosis and autophagy, and an imbalance of T helper cells, all of which are associated with pathological changes in allergic respiratory diseases. It is well known that particulates of different aerodynamic diameters and chemical compositions can result in different inflammatory responses in the respiratory tract. Detailed mechanistic studies on the effects of PM exposure are required, although development of T-helper cell imbalance seems to be a common effect of these PM particles (Fig. 1E). Moreover, there is currently no clinical consensus on the prevention or treatment of allergic symptoms associated with PM. Thus, the mechanisms underlying the interaction between PM and the immune system still need to be elucidated and addressed clinically. Furthermore, the biological effects of particulates are based on their chemical compositions, which vary substantially with the sources of pollution. Future studies on the chemical profiles of different particulates and their corresponding biological impacts should provide insights into their toxicology and information on the clinical treatment of allergic respiratory diseases caused by them.

Conflicts of interest

All authors have no conflicts of interest to disclose. The authors alone are responsible for the content and writing of the paper.
  63 in total

1.  Response of human alveolar macrophages to ultrafine, fine, and coarse urban air pollution particles.

Authors:  Susanne Becker; Joleen M Soukup; Constantinos Sioutas; Flemming R Cassee
Journal:  Exp Lung Res       Date:  2003 Jan-Feb       Impact factor: 2.459

2.  Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).

Authors:  L Hültner; C Druez; J Moeller; C Uyttenhove; E Schmitt; E Rüde; P Dörmer; J Van Snick
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

3.  Effects of fine particulate matter and its constituents on emergency room visits for asthma in southern Taiwan during 2008-2010: a population-based study.

Authors:  Su-Lun Hwang; Yu-Ching Lin; Chieh-Mo Lin; Kuang-Yu Hsiao
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-10       Impact factor: 4.223

4.  Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration.

Authors:  K Amin; J Rinne; T Haahtela; M Simola; C G Peterson; G M Roomans; H Malmberg; P Venge; L Sevéus
Journal:  J Allergy Clin Immunol       Date:  2001-02       Impact factor: 10.793

5.  Seasonal variation in chemical composition of size-segregated urban air particles and the inflammatory activity in the mouse lung.

Authors:  M S Happo; M-R Hirvonen; A I Hälinen; P I Jalava; A S Pennanen; M Sillanpää; R Hillamo; R O Salonen
Journal:  Inhal Toxicol       Date:  2010-01       Impact factor: 2.724

Review 6.  Atmospheric secondary inorganic particulate matter: the toxicological perspective as a basis for health effects risk assessment.

Authors:  Richard B Schlesinger; Flemming Cassee
Journal:  Inhal Toxicol       Date:  2003-03       Impact factor: 2.724

7.  PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.

Authors:  Xiaobei Deng; Wei Rui; Fang Zhang; Wenjun Ding
Journal:  Cell Biol Toxicol       Date:  2013-03-24       Impact factor: 6.691

Review 8.  The link between allergic rhinitis and asthma: a role for antileukotrienes?

Authors:  H Kim; J Bouchard; P M Renzi
Journal:  Can Respir J       Date:  2008-03       Impact factor: 2.409

9.  The effect of size-segregated ambient particulate matter on Th1/Th2-like immune responses in mice.

Authors:  Kuo-Liang Huang; Szu-Yuan Liu; Charles C K Chou; Yi-Hsin Lee; Tsun-Jen Cheng
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

10.  Short-term exposure to PM2.5 and vanadium and changes in asthma gene DNA methylation and lung function decrements among urban children.

Authors:  Kyung Hwa Jung; David Torrone; Stephanie Lovinsky-Desir; Matthew Perzanowski; Joshua Bautista; Jacqueline R Jezioro; Lori Hoepner; Jamie Ross; Frederica P Perera; Steven N Chillrud; Rachel L Miller
Journal:  Respir Res       Date:  2017-04-19
View more
  21 in total

1.  The impact of polar fraction of the fine particulate matter on redox responses in different rat tissues.

Authors:  Joaquim de Paula Ribeiro; Ana Cristina Kalb; Sabrina de Bastos Maya; Adriana Gioda; Pablo Elias Martinez; José Maria Monserrat; Braulio D Jiménez-Vélez; Carolina Rosa Gioda
Journal:  Environ Sci Pollut Res Int       Date:  2019-10-15       Impact factor: 4.223

2.  Study of Ce, Ca, Fe, and Mn-Doped LaCoO3 Perovskite Oxide for the Four-Way Purification of PM, NOx, CO, and HC from Diesel Engine Exhaust.

Authors:  Yinghui Wang; Xiurong Guo; Danfeng Du; Shaochi Yang
Journal:  Materials (Basel)       Date:  2022-06-10       Impact factor: 3.748

3.  Construction of polluted aerosol in accumulation that affects the incidence of lung cancer.

Authors:  Kriangsak Jenwitheesuk; Udomlack Peansukwech; Kamonwan Jenwitheesuk
Journal:  Heliyon       Date:  2020-02-08

4.  Impact of fossil fuel emissions and particulate matter on pulmonary health.

Authors:  Jonathan Kopel; Gregory L Brower
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-05

5.  Methods, availability, and applications of PM2.5 exposure estimates derived from ground measurements, satellite, and atmospheric models.

Authors:  Minghui Diao; Tracey Holloway; Seohyun Choi; Susan M O'Neill; Mohammad Z Al-Hamdan; Aaron Van Donkelaar; Randall V Martin; Xiaomeng Jin; Arlene M Fiore; Daven K Henze; Forrest Lacey; Patrick L Kinney; Frank Freedman; Narasimhan K Larkin; Yufei Zou; James T Kelly; Ambarish Vaidyanathan
Journal:  J Air Waste Manag Assoc       Date:  2019-10-15       Impact factor: 2.235

6.  Association between Green Space Structure and the Prevalence of Asthma: A Case Study of Toronto.

Authors:  Yuping Dong; Helin Liu; Tianming Zheng
Journal:  Int J Environ Res Public Health       Date:  2021-05-29       Impact factor: 3.390

7.  Benzo(a)pyrene facilitates dermatophagoides group 1 (Der f 1)-induced epithelial cytokine release through aryl hydrocarbon receptor in asthma.

Authors:  Eryi Wang; Xiaoyu Liu; Wei Tu; Danh C Do; Haiqiong Yu; Liteng Yang; Yufeng Zhou; Damo Xu; Shau-Ku Huang; Pingchang Yang; Pixin Ran; Pei-Song Gao; Zhigang Liu
Journal:  Allergy       Date:  2019-06-19       Impact factor: 13.146

Review 8.  Environmental Exposures and Asthma Development: Autophagy, Mitophagy, and Cellular Senescence.

Authors:  Karan Sachdeva; Danh C Do; Yan Zhang; Xinyue Hu; Jingsi Chen; Peisong Gao
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

Review 9.  Senescence in Pulmonary Fibrosis: Between Aging and Exposure.

Authors:  Alessandro Venosa
Journal:  Front Med (Lausanne)       Date:  2020-11-12

10.  Budesonide repairs decreased barrier integrity of eosinophilic nasal polyp epithelial cells caused by PM2.5.

Authors:  Siyuan Ma; Mu Xian; Yang Wang; Chengshuo Wang; Luo Zhang
Journal:  Clin Transl Allergy       Date:  2021-07-03       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.